Rajni Kannan on Risk Factors for Melanoma
Rajni Kannan, BS, MS, RN, ANP-BC, discusses some risk factors for melanoma that may not be widely known.
Rajni Kannan on the Nurse's Role in Skin Cancer Prevention Outreach
Rajni Kannan discusses the role of nurses in skin cancer prevention education.
Rajni Kannan Discusses Immune Related Adverse Events
Rajni Kannan, BS, MS, RN, ANP-BC, Perlmutter Cancer Center at NYU Langone, gives an overview of immune related adverse events (IRAEs).
Rajni Kannan on Discussing Clinical Trials with Cancer Patients
Rajni Kannan, BS, MS, RN, ANP-BC, Perlmutter Cancer Center at NYU Langone, explains the importance of discussing clinical trials with cancer patients in order to clear up any misconceptions.
Rajni Kannan on the Side Effects of Yervoy and Zelboraf
Rajni Kannan discusses the importance patient education or managing the side effects associated ipilimumab and vemurafenib in metastatic melanoma.
Orca-T Provides Post-HCT Survival Benefits vs PTCy in Blood Cancers
Immune Engager Therapies Improve Responses, PFS in RRMM After CAR T-Cell Therapy
Liso-Cel Elicits Rapid, Durable Responses in Relapsed/Refractory CLL/SLL
Adding Azoles May Not Impact Efficacy of Ruxolitinib in Acute GVHD Treatment
2 Commerce Drive Cranbury, NJ 08512